Eric J. Chow

Appointments and Affiliations

Fred Hutchinson Cancer Research Center
Clinical Research Division
Pediatric Oncology
Associate Member
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Cancer Epidemiology Research Cooperative
Associate Member
Seattle Children's Hospital
Cancer Survivor Program
LIVESTRONG Survivorship Center of Excellence
Medical Director, Appointed: 2008
University of Washington
Department of Pediatrics
Acting Associate Professor
Professional Headshot of NAME

Mailing Address

Fred Hutchinson Cancer Research Center
P.O. Box 19024
Seattle, Washington 98109-1024
United States


Phone: (206) 667-7724
Fax: (206) 667-5948


M.D. with thesis, University of California, San Francisco, 2001.
M.P.H., University of California, Berkeley, Epidemiology and Biostatistics, 2000.
B.S., Yale University, Biology with distinction, magna cum laude, 1996.

Research Interests and Clinical Expertise

Late effects related to pediatric cancer and blood disorder therapy.

Previous Positions

2007-2011: Research Associate, Fred Hutchinson Cancer Research Center.
2007-2009: Acting Instructor, University of Washington, Department of Pediatrics.
2004-2007: Pediatric Hematology, Oncology Fellowship, UW-Seattle Children's Hospital-Fred Hutchinson Cancer Research Center.
2001-2004: Pediatric Categorical Residency, University of Washington-Seattle Children's Hospital.

Additional Experience

Children’s Oncology Group
Survivorship Guidelines Task Force
Co-chair, Hematopoietic cell transplantation/Immune complications, 2009-present
Chair, Obesity/Metabolic syndrome, 2007-2010
Outcomes & Survivorship Steering Committee, 2008-present


Childhood Cancer Survivor Study (CCSS)
Steering/Executive Committee, 2008-present
Publication Committee, 2010-present


Center for International Blood and Marrow Transplant Research (CIBMTR)
Late Effects Working Committee, 2010-present


Pediatric Hematology-Oncology Fellowship Selection Committee


University of Washington, 2007


Center for Clinical & Translational Research, Education Committee Seattle Children’s Hospital, 2008-present


Obesity Program Clinical Working Group Seattle Children’s Hospital, 2009-10


Scientific Review Committee Seattle Children’s Hospital, 2010-present


American Society of Hematology, 2009-present.
Children’s Oncology Group, 2008-present
American Society of Clinical Oncology, 2007-present
American Society for Blood and Marrow Transplantation, 2004-present

Honors and Awards

Leukemia & Lymphoma Society Special Fellowship in Clinical Research, 2008-2011.
American Society for Blood & Marrow Transplantation New Investigator Award, 2008-2010.
American Society of Clinical Oncology Young Investigator Award, 2007-2008.
University Fellowship, University of California, Berkeley, 1999-2000.
Phi Beta Kappa, Yale University, 1996.

Board Certification and Eligibility

Pediatric Hematology-Oncology, 2009-2016.
General Pediatrics, 2004-2011.

Current License(s) to Practice

Washington State License, 2004-present.

Editorial Positions

Ad hoc reviewer:
  • American Journal of Epidemiology
  • Biology of Blood and Marrow Transplantation
  • Cancer
  • Cancer Causes & Control
  • Cancer Epidemiology, Biomarkers & Prevention
  • International Journal of Cancer
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer


  • K07 CA151775-01A1 (PI: Chow, E) 8/1/2011-7/30/2016. Determinants of late cardiovascular morbidity among survivors of hematopoietic cell transplantation.
  • FND (PI: Chow, E) 10/1/2008-12/31/2012. Hyundai Hope on Wheels Cancer Research Scholarship. Glucocorticoids and insulin resistance among children undergoing treatment for acute lymphoblastic leukemia.
  • U24CA 55727 (PI: Robison, L) 12/1/2011-11/30/2016. Childhood Cancer Survivor Study is an NCI-funded resource study whose primary goal is to study the late effects among a cohort of childhood cancer survivors. Role: co-investigator, Executive Committee member.
  • R01 CA112530 (PI: Baker, KS) 8/15/2006–7/31/2012. Metabolic syndrome following transplant for leukemia. Evaluate the relationship between HCT specific treatment exposures and the development of insulin resistance and the MS in adolescent and young adult survivors after HCT for treatment of hematologic malignancies in childhood Role: co-investigator.

Recent Publications


Coming Soon: New Profiles System!

In preparation for the launch of our new profiles system, we are freezing updates to these profiles. If you have any questions, please email

Researcher Profiles


Related Websites


Scientific Divisions